Results 1 to 20 of 63
Page 1 of 4  Next >
TypeTitleAuthor(s)YearViews
Evidence of serologic activity in chronic hepatitis B after surface antigen (HBsAg) seroclearance documented by conventional HBsAg assaySeto, WK; Tanaka, Y; Wong, DKH; Lai, CL; Shinkai, N; Yuen, JCH; Tong, T; Fung, J; Hung, IFN; Yuen, MF2013142
 
Outcome of lamivudine-resistant chronic hepatitis B after up to 5 years of combination therapy with adefovirSeto, WK; Liu, K; Fung, J; Wong, DKH; Yuen, JCH; Hung, IFN; Lai, CL; Yuen, MF201299
 
A large case-control study on the predictability of hepatitis B surface antigen levels three years before hepatitis B surface antigen seroclearanceSeto, WK; Wong, DKH; Fung, J; Hung, IFN; Fong, DYT; Yuen, JCH; Tong, T; Lai, CL; Yuen, MF2012133
 
Serologic and virologic kinetics after stopping nucleoside analogue therapy in hepatitis B surface antigen (HBSAG) seroclearanceSeto, WK; Wong, DKH; Fung, J; Yuen, JCH; Hung, IFN; Lai, CL; Yuen, RMF201295
 
Serum hepatitis B surface antigen (HBsAg) kinetics in hepatitis B e antigen (HBeAg)-negative chronic hepatitis BSeto, WKW; Wong, DKH; Fung, JYY; Hung, IFN; Yuen, JCH; Tong, T; Lai, CL; Yuen, RMF201247
 
A large population histology study showing the lack of association between ALT elevation and significant fibrosis in chronic hepatitis BSeto, WK; Lai, CL; Ip, PPC; Fung, J; Wong, DKH; Yuen, JCH; Hung, IFN; Yuen, MF2012184
 
High hepatitis B surface antigen levels predict insignificant fibrosis in hepatitis B e antigen positive chronic hepatitis BSeto, WK; Wong, DKH; Fung, J; Ip, PPC; Yuen, JCH; Hung, IFN; Lai, CL; Yuen, MF2012137
 
Three years of continuous entecavir therapy in treatment-nave chronic hepatitis B patients: VIRAL suppression, viral resistance, and clinical safetyYuen, MF; Seto, WK; Fung, J; Wong, DKH; Yuen, JCH; Lai, CL20111,336
 
Evidence of serologic activity in chronic hepatitis B after surface antigen (HBSAG) seroclearanceSeto, WK; Tanaka, Y; Wong, D; Lai, CL; Shinkai, N; Yuen, JCH; Tong, TSM; Fung, J; Hung, IFN; Yuen, MF201166
 
Elevation of ALT fails to predict significant histologic abnormalities in chronic hepatitis B patients.Seto, WK; Lai, CL; Fung, JYY; Yuen, JCH; Wong, DKH; Yuen, RMF2011157
 
Serum hepatitis B surface antigen (HBSAG) titers and HBV DNA levels in Hepatitis B E antigen (HBEAG)-negative chronic Hepatitis B: an interim analysisSeto, WK; Lai, CL; Fung, J; Wong, D; Yuen, JCH; Young, JLP; Tong, TSM; Hung, IFN; Yuen, MF201164
 
Significance of HBV DNA levels at 12 weeks of telbivudine treatment and the 3 years treatment outcomeSeto, WK; Lai, CL; Fung, J; Wong, DKH; Yuen, JCH; Hung, IFN; Yuen, MF2011246
 
High prediction of hepatitis B surface antigen (HBsAg) seroclearance at 3 years of follow-up by measuring HBsAg titersSeto, WK; Lai, CL; Fung, J; Wong, D; Yuen, JCH; Young, JLP; Tong, TSM; Hung, IFN; Yuen, MF201186
 
HBV DNA levels after 12 weeks of telbivudine treatment in chronic hepatitis B predicts long-term outcomeSeto, WK; Lai, CL; Fung, J; Wong, D; Yuen, JCH; Hung, IFN; Yuen, MF2010169
 
Prevalence of occult hepatitis B infection in a highly endemic area for chronic hepatitis B: A study of a large blood donor populationYuen, MF; Lee, CK; Wong, DKH; Fung, J; Hung, I; Hsu, A; But, DYK; Cheung, TK; Chan, P; Yuen, JCH; Fung, FKC; Seto, WK; Lin, CK; Lai, CL2010642
 
Combination of baseline parameters and on-treatment hepatitis B virus DNA levels to start and continue patients with lamivudine therapyYuen, MF; Fung, J; Seto, WK; Wong, DKH; Yuen, JCH; Lai, CL2009140
 
Increase risk of HBeAg-negative chronic hepatitis B with older age at HBeAg seroconversionFung, JYY; Lai, CL; Wong, DKH; Yuen, JCH; Yuen, RMF2009165
 
Association of hepatitis B virus Pre-S mutations with the risk of hepatocellular carcinoma developmentYeung, P; Wong, DKH; Fung, JYY; Yuen, JCH; Fung, FKC; Lai, CL; Yuen, RMF2009237
 
Association of hepatitis B virus pre-S deletions with the risk of development of hepatocellular carcinomaYeung, P; Wong, DKH; Fung, JYY; Yuen, JCH; Fung, FKC; Lai, CL; Yuen, RMF2009184
 
Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis BYuen, MF; Tanaka, Y; Fong, DYT; Fung, J; Wong, DKH; Yuen, JCH; But, DYK; Chan, AOO; Wong, BCY; Mizokami, M; Lai, CL2009448
 
Page 1 of 4  Next >
Export Records
Step 1: Select content and export format
  • Citation only
Step 2: Select export method
  • Download